Module 1 - Neoplasms

Module 1 - Neoplasms

CNE INFORMATION

Title of Activity:
DCNP On-line Review Course – Module 1 - Neoplasms

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Margaret Macy, Krista Rubin, NP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 3 hours and 36 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 3.6 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of neoplasms.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors
  • Summarize recognized pathogenesis of theories thereof
  • List common and if available pathognomic features
  • Describe identified contributing pathological features
  • Choose appropriate diagnoses to include in the differential
  • Explain applicable treatement plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

Katrina Masterson, DNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:

Theresa Coyner, RN, MSN, ANP-BC, DCNP; Margaret Macy, Krista Rubin, NP

has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support - Sanofi-Regeneron

Activities Included:

Actinic Keratosis

Basal Cell Carcinoma

Cutaneous T-Cell Lymphoma (CTCL)

Cutaneous B Cell Lymphoma

Dermatofibroma

Immunosuppression

Keratoacanthoma

Mastocytosis

Melanoma

Seborrheic Keratosis

Sezary Syndrome

Squamous Cell Carcinoma (SCC)

CE Test

Evaluation


Module 2 - Papulosquamous and Eczematous Deramatoses

Module 2 - Papulosquamous and Eczematous Deramatoses

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 2 – Papulosquamous and Eczematous Dermatoses

Faculty: Donna Fichera, MSN, RN, DNC; Theresa Coyner, RN, MSN, ANP-BC, DCNP; Emily Jorge, DCNP; Maggie Macy, Tracy Nelson, MSN, FNP-BC, DCNP; Jenn Blattner, ARNP, FNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 2 hours and 30 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 2.79 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of papulosquamous and eczematous dermatoses.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors
  • Summarize recognized pathogenesis of theories thereof
  • List common and if available pathognomic features
  • Choose appropriate diagnoses to include in the differential
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence
  • Locate resources for further study

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner

Katrina Masterson, DNP, Nurse Planner

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:

Donna Fichera, MSN, RN, DNC; Theresa Coyner, RN, MSN, ANP-BC, DCNP; Emily Jorge, DCNP; Maggie Macy, Tracy Nelson, MSN, FNP-BC, DCNP; Jenn Blattner, ARNP, FNP has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support:  Sanofi Regeneron

Activities Included:

Atopic Dermatitis

Contact Dermatitis

Eosinophilic Pustular Folliculitis

Erythroderma

Grover’s Disease

Intertrigo

Keratosis Pilaris

Lichen Planus

Lichen Simplex Chronicus

Nummular Eczema

Phototherapy

Pityriasis Alba

Pityriasis Lichenoides

Pityriasis Rosea

Pityriasis Rubra Pilaris

Pruritic Urticarial Papules and Plaques of Pregnancy

Psoriasis

Seborrheic Dermatitis

Stasis Dermatitis

Xerosis Cutis

CE Test

Evaluation


Module 3 - Urticarias, Erythemas, Photosensitivities, & Purpuras

Module 3 - Urticarias, Erythemas, Photosensitivities, & Purpuras

CNE INFORMATION

Title of Activity: DCNP On-Line Review Course – Module 3 – Urticarias, Erythemas, Photosensitivities, Purpuras

Faculty: Katrina Masterson, DNP; Theresa Coyner, RN, MSN, ANP-BC, DCNP;

Anne St. Pierre

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 3 hours

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 3.0 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of urtiicarias, erythemas, photosensitivities and purpuras. 

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors.
  • Summarize recognized pathogenesis of theories thereof.
  • List common and if available pathognomic features.
  • Describe identified contributing pathological features.
  • Choose appropriate diagnoses to include in the differential.
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

Katrina Masterson, DNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty: Katrina Masterson, DNP; Theresa Coyner, RN, MSN, ANP-BC, DCNP; Anne St. Pierre

has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial support – Sanofi-Regeneron

Activities Included:

Drug Eruptions

Erythema Multiforme

Panniculitis

Polymorphic Light Eruptions (PMLE)

Pyoderma Gangrenosum

Sweet’s Syndrome

Urticaria and Angioedema

Vasculitis

CE Test

Evaluation


Module 4 - Infections, Infestations, & Bites

Module 4 - Infections, Infestations, & Bites

CNE INFORMATION

Title of Activity: DCNP On-Line Review Course – Module 4 – Infections, Infestations, & Bites

Faculty: Katrina Masterson, DNP; Theresa Coyner, RN, MSN, ANP-BC, DCNP;

Olanda Hathaway, CRNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 1 hour and 42 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 7.7 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of infections, infestations and bites.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors.
  • Summarize recognized pathogenesis of theories thereof.
  • List common and if available pathognomic features.
  • Describe identified contributing pathological features.
  • Choose appropriate diagnoses to include in the differential.
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

Katrina Masterson, DNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty: Katrina Masterson, DNP; Theresa Coyner, RN, MSN, ANP-BC, DCNP; Olanda Hathaway, CRNP

has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial support – Sanofi-Regeneron

Activities Included:

Anthrax

Bites and Stings

Candidiasis

Cellulitis

Cutaneous Larva Migrans

Abscesses, Furuncles & Carbuncles

Fungal Infections

Gianotti – Crosti Syndrome

Herpetic Infections

Human Papillomavirus HPV

Leprosy Hansen’s Disease

Impetigo

Leishmaniasis

Molluscum Contagiosum (MC)

Pediculosis

Psychodermatoses

Scabies

Smallpox

Staphylococcal Scalded Skin Syndrome SSSS

Syphilis

CE Test

Evaluation


Module 5 - Adnexal Diseases

Module 5 - Adnexal Diseases

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 5 – Adnexal Diseases

Faculty: Nicki Sherer; Cindy Cloud, MSN, ANP-BC, DCNP; Theresa Coyner, RN, MSN, ANP-BC, DCNP; Kim Carlson, RN, MSN, NP-C, DCNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 45 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 0.75 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members.

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of adnexal diseases.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors
  • Summarize recognized pathogenesis of theories thereof
  • List common and if available pathognomic features
  • Describe identified contributing pathological features
  • Choose appropriate diagnoses to include in the differential
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on know standards and evidence
  • Locate resources for further study

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Katrina Masterson, DNP, FNP-BC, DCNP, Nurse Planner/Content Expert

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty: Nicki Sherer, Cindy Cloud, MSN, ANP-BC, DCNP; Theresa Coyner, RN, MSN, ANP-BC, DCNP; Kim Carlson, RN, MSN, NP-C, DCNP

has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support:  Sanofi-Regeneron

Activities Included:

Acne

Acne Keloidalis

Hidradenitis Suppurativa (HS)

Perioral Dermatitis

Primary Focal Hyperhidrosis

Rosacea

Sebaceous Hyperplasia

CE Test

Evaluation


Module 6 - Vesiculobullous, Autoimmune, & Connective Tissue Diseases

Module 6 - Vesiculobullous, Autoimmune, & Connective Tissue Diseases

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 6 – Vesiculobullous, Autoimmune & Connective Tissue Diseases

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Andrea Frantz-Iverson, APRN, (DNP Student); Liz Pettit

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 5 hours and 48 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 5.8 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members.

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of Vesiculobullous, Autoimmune, & Connective Tissue Diseases.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors.
  • Summarize recognized pathogenesis of theories thereof.
  • List common and if available pathognomic features
  • Describe identified contributing pathological features
  • Choose appropriate diagnoses to include in the differential.
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Katrina Masterson, DNP, FNP-BC, DCNP, Nurse Planner/Content Expert

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:  Theresa Coyner, RN, MSN, ANP-BC, DCNP; Andrea Frantz-Iverson, APRN, (DNP Student); Liz Pettit has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support:  Sanofi-Regeneron

Activities Included:

Dermatitis Herpetiformis

Dermatomyositis

Ehlers-Danlos Syndrome

Epidermolysis Bullosa

Hypertrophic Scars And Keloids

Linear IgA Bullous Dermatosis

Lupus Erythematosus

Morphea

Pemphigoid

Pemphigus

Sarcoidosis

Scleroderma

CE Test

Evaluation


Module 7 - Pigmentary/Vacular Disorders

Module 7 - Pigmentary/Vacular Disorders

CNE INFORMATION

Title of Activity: DCNP On-Line Review Course – Module 7 – Pigmentary/Vascular Disorders

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Krista Rubin, NP;

Emily Jorge, DCNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 2 hours

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 2.0 ANCC contact hours

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members.

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose: The purpose of this activity is to provide the learner with knowledge and review of pigmentary/vascular disorders.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors.
  • Summarize recognized pathogenesis of theories thereof.
  • List common and if available pathognomic features.
  • Describe identified contributing pathological features.
  • Choose appropriate diagnoses to include in the differential.
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

Katrina Masterson, DNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Krista Rubin, NP;

Emily Jorge, DCNP has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial support – Sanofi-Regeneron

Activities Included:

Confluent and Reticulated Papillomatosis

Cosmetics and Lasers

Disorders of Hyperpigmentation

Disorders of Pigmentation

Hemangiomas

Melasma

Nevi

Port Wine Stain

Sturge-Weber Syndrome

Vitiligo

CE Test

Evaluation


Module 8 - Photodamage/Cosmetic Surgery

Module 8 - Photodamage/Cosmetic Surgery

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 8 – Photodamage/Cosmetic Surgery

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 1 hour and 20 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.  This activity is awarded 1.33 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:  The purpose of this activity is to provide the learner with knowledge and review of photodamage and cosmetic surgery.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors
  • Summarize recognized pathogenesis of theories thereof
  • List common and if available pathognomic features
  • Describe identified contributing pathological features
  • Choose appropriate diagnoses to include in the differential
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Katrina Masterson, DNP, FNP-BC, DCNP, Nurse Planner/Content Expert

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:  Theresa Coyner, RN, MSN, ANP-BC, DCNP

has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support:  Sanofi-Regeneron

Activities Included:

Elastosis

Favre-Racouchot

Lentigos

Poikiloderma of Civatte

Telangiectasia

Xanthomas

CE Test

Evaluation


Module 9 - Systemic Diseases and Genodermatoses

Module 9 - Systemic Diseases and Genodermatoses

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 9 – Systemic Disease & Genodermatoses

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Olanda Hathway, CRNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 3 hours and 30 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 3.5 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of systemic disease and genodermatoses.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors.
  • Summarize recognized pathogenesis of theories thereof.
  • List common and if available pathognomic features
  • Describe identified contributing pathological features
  • Choose appropriate diagnoses to include in the differential.
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Katrina Masterson, DNP, FNP-BC, DCNP, Nurse Planner/Content Expert

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:  Theresa Coyner, RN, MSN, ANP-BC, DCNP; Olanda Hathaway, CRNP has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support:  Sanofi-Regeneron

Activities Included:

Amyloidosis

Cutaneous Signs of Systemic Disease Pruritus

Darier Disease

Hailey-Hailey Disease

Histiocytosis

Ichthyoses

Inflammatory Linear Verrucous Intradermal Nevus (ILVEN)

Keratodermas

Neurofibromatosis

Porphyria

Signs of Drug Abuse

CE Test

Evaluation


Module 10 - Hair, Nails and Mucous Membrane Disorders

Module 10 - Hair, Nails and Mucous Membrane Disorders

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 10 – Hair, Nails & Mucous Membrane Disorders

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Val Edwards, NP-C; Tiffany Engelken, ARNP-C, DCNP; Katrina Masterson, DNP, FNP-BC, DCNP; Tracy Nelson, MSN, FNP-BC, DCNP

Release Date: June 15, 2018

Expiration Date: May 31, 2021

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 1 hour and 48 minutes

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 1.8 ANCC contact hour(s).

The fee for the entire package of 11 modules is: $500 DNA Members/$800 Non-Members

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

The purpose of this activity is to provide the learner with knowledge and review of hair, nails and mucous membranes.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Describe known epidemiologic factors.
  • Summarize recognized pathogenesis of theories thereof.
  • List common and if available pathognomic features
  • Describe identified contributing pathological features
  • Choose appropriate diagnoses to include in the differential.
  • Explain applicable treatment plan, pharmacologic and non-pharmacologic, as available based on known standards and evidence.
  • Locate resources for further study.

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Katrina Masterson, DNP, FNP-BC, DCNP, Nurse Planner/Content Expert

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:  Theresa Coyner, RN, MSN, ANP-BC, DCNP; Val Edwards, NP-C; Tiffany Engelken, ARNP-C, DCNP; Katrina Masterson, DNP, FNP-BC, DCNP;  Tracy Nelson, MSN, FNP-BC, DCNP has disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

Commercial Support:  Sanofi-Regeneron

Activities Included:

Alopecia

Behçet Syndrome or Disease

Lichen Sclerosus (LS)

Nail Dystrophies

Paronychia

Sjögren Syndrome

CE Test

Evaluation


Module 11 - Pharmacological Medications Encountered in a General Medical Surgical Dermatology Practice

Module 11 - Pharmacological Medications Encountered in a General Medical Surgical Dermatology Practice

CNE INFORMATION

Title of Activity: DCNP On-line Review Course – Module 11 –Pharmacological Medications Encountered in a General Medical Surgical Dermatology Practice

Faculty: Theresa Coyner, RN, MSN, ANP-BC, DCNP; Katrina Masterson, DNP, FNP-BC

Release Date: June 15, 2018

Expiration Date: May 31, 2019

Target Audience: 

Dermatologic Nurse Practitioners preparing to take the Dermatology Certified Nurse Practitioner (DCNP) exam and other Nurses and Nurse Practitioners who care for patients with dermatologic conditions.

Estimated time for completion: 7 hours

CREDIT INFORMATION

Nurses:

The Dermatology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is awarded 7.0 contact hours.

Nurse Practitioners:

This activity is approved for 7.0 contact hour(s) of continuing education (which includes 7.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18053199. This activity was planned in accordance with AANP CE Standards and Policies

To Receive Credit:

  1. View the PowerPoint in its entirety.
  2. Complete/submit the post test and evaluation.
  3. Receive a passing score of 70% or more to receive credit.
  4. Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose:

  The purpose of this activity is to provide the learner with knowledge of dermatological medications regarding mode of action, indications, dosing, potential adverse reactions, potential medication interactions, and monitoring guidelines.

Learning Objectives

Upon successful completion of this educational program, the participant should be able to:

  • Identify mode of action of various dermatologic medications
  • Describe indications for various dermatologic medications
  • Determine appropriate dosing of various dermatologic medications
  • Describe potential adverse reactions and medication interactions of various dermatologic medications
  • Define appropriate monitoring guidelines for various dermatologic medications

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Katrina Masterson, DNP, FNP-BC, DCNP, Nurse Planner/Content Expert

Theresa Coyner, RN, MSN, ANP-BC, DCNP, Nurse Planner/Content Expert

have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:  Theresa Coyner, RN, MSN, ANP-BC, DCNP; Katrina Masterson, DNP, FNP-BC, DCNP, have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT

Commercial Support:  Sanofi-Regeneron

Activities Included:

DNA Dermatologic Medications Pt 1

DNA Dermatologic Medications Pt 2

DNA Dermatologic Medications Pt 3

CE Test

Evaluation